Literature DB >> 34907598

The double-edged sword effect of HDAC6 in Aβ toxicities.

Kuan-Chung Cheng1,2, Yu-Luen Hwang1, Hsueh-Cheng Chiang1,2.   

Abstract

Alzheimer's disease (AD) is marked by cognitive impairment, massive cell death, and reduced life expectancy. Pathologically, accumulated beta-amyloid (Aβ) aggregates and hyperphosphorylated tau protein is the hallmark of the disease. Although changes in cellular function and protein accumulates have been demonstrated in many different AD animal models, the molecular mechanism involved in different cellular functions and the correlation and causative relation between different protein accumulations remain elusive. Our in vivo genetic studies revealed that the molecular mechanisms involved in memory loss and lifespan shortening are different and that tau plays an essential role in mediating Aβ-induced early death. We found that when the first deacetylase (DAC) domain of histone deacetylase 6 (HDAC6) activity was increased, it regulated cortactin deacetylation to reverse Aβ-induced learning and memory deficit, but with no effect on the lifespan of the Aβ flies. On the other hand, an increased amount of the second DAC domain of HDAC6 promoted tau phosphorylation to facilitate Aβ-induced lifespan shortening without affecting learning performance in the Aβ flies. Our data also confirmed decreased acetylation in two major HDAC6 downstream proteins, suggesting increased HDAC6 activity in Aβ flies. Our data established the double-edged sword effect of HDAC6 activity in Aβ-induced pathologies. Not only did we segregate memory loss and lifespan shortening in Aβ flies, but we also provided evidence to link the Aβ with tau signaling.
© 2021 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  Aβ; HDAC6; learning and memory; tau

Mesh:

Substances:

Year:  2022        PMID: 34907598     DOI: 10.1096/fj.202101061R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  1 in total

1.  Development of a potential PET probe for HDAC6 imaging in Alzheimer's disease.

Authors:  Ping Bai; Prasenjit Mondal; Frederick A Bagdasarian; Nisha Rani; Yan Liu; Ashley Gomm; Darcy R Tocci; Se Hoon Choi; Hsiao-Ying Wey; Rudolph E Tanzi; Can Zhang; Changning Wang
Journal:  Acta Pharm Sin B       Date:  2022-05-20       Impact factor: 14.903

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.